pyrazines has been researched along with Leukemia, Lymphoid in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ball, G; Beran, M; Cortes-Franco, JE; Divoky, V; Gatto, S; Kantarjian, HM; Keating, MJ; Milella, M; Onida, F; Pham, L; Ricci, C; Scappini, B; Verstovsek, S | 1 |
Armstrong, JS; Boelsterli, U; Chua, YL; Moore, PK; Whiteman, M; Zhang, D | 1 |
2 other study(ies) available for pyrazines and Leukemia, Lymphoid
Article | Year |
---|---|
The proteasome inhibitor PS-341 inhibits growth and induces apoptosis in Bcr/Abl-positive cell lines sensitive and resistant to imatinib mesylate.
Topics: Apoptosis; Benzamides; Boronic Acids; Bortezomib; Caspase 3; Caspases; Cell Cycle; Cell Line, Tumor; Cysteine Endopeptidases; Cysteine Proteinase Inhibitors; DNA-Binding Proteins; Drug Combinations; Drug Resistance, Neoplasm; Fusion Proteins, bcr-abl; Gene Expression Regulation, Neoplastic; Genes, abl; Humans; I-kappa B Proteins; Imatinib Mesylate; Leukemia, Lymphoid; Leukemia, Myeloid; Multienzyme Complexes; NF-kappa B; NF-KappaB Inhibitor alpha; Phosphorylation; Piperazines; Proteasome Endopeptidase Complex; Pyrazines; Pyrimidines | 2003 |
Oltipraz-induced phase 2 enzyme response conserved in cells lacking mitochondrial DNA.
Topics: Anticarcinogenic Agents; Cell Line, Tumor; Cell Survival; DNA, Mitochondrial; Glutathione; Glutathione Transferase; Humans; Leukemia, Lymphoid; Membrane Potentials; Mitochondria; Oxidative Stress; Pyrazines; Reactive Oxygen Species; Thiones; Thiophenes | 2005 |